Insider Transactions in Q2 2019 at Next Cure, Inc. (NXTC)
Insider Transaction List (Q2 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 13
2019
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
350,000
+11.43%
|
$5,250,000
$15.0 P/Share
|
|
May 13
2019
|
Orbimed Advisors LLC Director |
BUY
Conversion of derivative security
|
Indirect |
2,361,013
+32.95%
|
-
|
|
May 13
2019
|
Canaan X L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
50,000
+2.17%
|
$750,000
$15.0 P/Share
|
|
May 13
2019
|
Canaan X L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,204,442
+31.87%
|
-
|